Uzun, G. S. Et Al. 2022. DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1264-1265.

Uzun, G. S., Tatar, O. D., Gezerer, N. E., Bilgin, E., Yardimci, G. K., Bolek, E. C., ... Farisogullari, B.(2022). DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1264-1265.

Uzun, G. Et Al. "DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1264-1265, 2022

Uzun, G. S. Et Al. "DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1264-1265, 2022

Uzun, G. S. Et Al. (2022) . "DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1264-1265.

@article{article, author={G. Sandal Uzun Et Al. }, title={DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1264-1265} }